Personality Disorders - Nursing Case Study
Pathophysiology
• Primary mechanism: Altered brain structure and function, particularly in areas like the prefrontal cortex and amygdala, can lead to impaired emotional regulation and decision-making, contributing to the development of personality disorders.
• Secondary mechanism: Neurotransmitter imbalances, especially involving serotonin and dopamine, may influence mood and behavior, exacerbating symptoms of personality disorders.
• Key complication: These mechanisms can result in pervasive and maladaptive patterns of thinking and behavior, leading to significant impairments in social, occupational, and interpersonal functioning, which are hallmark features of personality disorders.
Patient Profile
Demographics:
32-year-old female, graphic designer
History:
• Key past medical history: Major depressive disorder, anxiety disorder, brief hospitalization for a manic episode two years ago
• Current medications: Fluoxetine 20 mg daily, Lorazepam 1 mg as needed, Lamotrigine 100 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing difficulty managing interpersonal relationships and emotional regulation
• Key symptoms: Mood swings, impulsivity, fear of abandonment, episodes of intense anger, and identity disturbance
• Vital signs: Blood pressure 140/90 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F
Section 1
Change in Patient Status:
Over the past two weeks, the patient's condition has shown signs of deterioration, marked by an increase in both the frequency and intensity of her mood swings and impulsive behaviors. She reports a recent incident at work where she abruptly left a meeting due to feeling overwhelmed by a perceived criticism, leading to a heated confrontation with a colleague. This event has heightened her fear of job loss and exacerbated her anxiety about abandonment, both in professional and personal settings. Her sleep patterns have become erratic, contributing to her heightened emotional lability.
During a follow-up appointment, her vital signs reveal a slightly elevated blood pressure of 150/95 mmHg and a heart rate of 102 bpm. The patient describes persistent feelings of emptiness and admits to engaging in reckless spending as a way to cope with her internal distress. A physical examination reveals no acute physical ailments, but her mental status exam highlights significant emotional instability and difficulty maintaining consistent, rational thought processes. She exhibits black-and-white thinking, especially concerning her relationships, where she alternates between idealizing and devaluing others.
The clinical team is concerned about the potential development of a borderline personality disorder, given the pattern of instability in her interpersonal relationships, self-image, and affective regulation. To address these concerns, the team considers adjusting her current medication regimen and integrating dialectical behavior therapy (DBT) to better target the emotional dysregulation and interpersonal difficulties. This change in strategy aims to provide her with more effective tools for managing her symptoms and preventing further complications in her personal and professional life.
Section 2
Response to Interventions:
Following the integration of dialectical behavior therapy (DBT) and a reassessment of her medication regimen, the patient demonstrates some initial improvement in emotional regulation and interpersonal interactions. Over the next week, she attends several DBT sessions, focusing on mindfulness and distress tolerance skills. Her therapist notes her increased engagement during sessions and a willingness to practice these skills in real-life situations, such as using breathing exercises to manage her anxiety when feeling criticized at work. Her medication, adjusted to include a low-dose selective serotonin reuptake inhibitor (SSRI), appears to stabilize her mood swings slightly, as evidenced by a decrease in impulsive behaviors like reckless spending.
However, despite these positive indications, the patient reports continued difficulty with sleep, which impacts her energy levels and concentration at work. Her blood pressure, while slightly decreased, remains elevated at 145/90 mmHg, and her heart rate is 98 bpm, suggesting persistent physiological stress. A follow-up mental status exam reveals some improvement in her thought processes; she expresses a more nuanced understanding of her relationships, though she continues to struggle with feelings of emptiness and worthlessness.
The clinical team acknowledges the progress but notes the ongoing challenges in managing her symptoms. They emphasize the importance of continued therapy and medication adjustments, alongside lifestyle interventions such as regular exercise and routine sleep hygiene practices. They also plan to monitor her cardiovascular status closely, given the persistent hypertension, to prevent further complications. This ongoing assessment allows for adaptive strategies, ensuring the patient has comprehensive support as she navigates her emotional and physical health challenges.
Section 3
As the patient continues her treatment, a new complication arises. She begins experiencing sudden and unexplained episodes of dizziness and lightheadedness, particularly when standing up quickly. Concerned about these symptoms, the clinical team orders a series of diagnostic tests, including a complete blood count (CBC), a comprehensive metabolic panel (CMP), and an electrocardiogram (ECG) to rule out potential causes such as anemia, electrolyte imbalances, or cardiac issues. The results reveal a mild hyponatremia, with her sodium level at 132 mEq/L, which may be contributing to her dizziness. Additionally, her ECG shows a borderline prolonged QT interval, raising concerns about potential cardiac side effects from her SSRI medication.
Recognizing the significance of these findings, the clinical team convenes to reassess the patient’s treatment plan. They consider the possibility that her SSRI may be contributing to both the hyponatremia and the prolonged QT interval. A decision is made to adjust her medication regimen by gradually tapering the current SSRI and considering an alternative that has a lower risk for these specific side effects. In parallel, the team emphasizes the importance of dietary adjustments to address the sodium imbalance and recommends increasing her intake of sodium-rich foods under the guidance of a dietitian. They also reinforce the importance of hydration to maintain electrolyte balance.
As these changes are implemented, the patient is closely monitored for improvements in her symptoms and overall stability. The team remains vigilant, aware that the interplay between her psychological and physiological conditions requires a delicate balance of interventions. They continue to encourage her active participation in DBT and lifestyle modifications, while planning regular follow-ups to evaluate her response to the adjusted treatment plan. This integrated approach is crucial to managing her complex case and preventing further complications, ensuring that she receives the holistic care needed to navigate her ongoing challenges.
Section 4
As the patient progresses with her adjusted treatment plan, the clinical team closely monitors her response to the interventions. Over the following weeks, her symptoms of dizziness and lightheadedness begin to diminish, suggesting a positive response to the medication adjustments and dietary recommendations. Her sodium levels gradually improve, with the latest lab results showing a sodium level of 136 mEq/L, indicating a return to normal range. The team notes that her QT interval on the ECG has also normalized, reducing concerns about cardiac side effects. Her vital signs remain stable, with a blood pressure of 118/76 mmHg and a heart rate of 72 beats per minute, both within normal limits.
However, a new challenge arises as the patient reports experiencing increased anxiety and agitation, particularly in the evenings. This change in her mental state prompts the team to consider the possibility that the tapering of her SSRI is contributing to these symptoms. They conduct a thorough assessment to evaluate the severity of her anxiety, noting that she rates her anxiety level as 7 out of 10 on the severity scale. Additionally, she describes difficulty sleeping and a persistent sense of restlessness.
Recognizing the need for a delicate balance in her treatment, the team discusses potential adjustments to her medication regimen. They consider introducing a low-dose benzodiazepine to address her acute anxiety symptoms while continuing to monitor her electrolyte levels and cardiac status closely. The team emphasizes the importance of maintaining her engagement in DBT to help her develop coping strategies for her anxiety. With a comprehensive and adaptive approach, they aim to support her mental health while preventing further physiological complications, ensuring a stable path forward in her treatment journey.
Section 5
Over the following week, the clinical team observes the patient's response to the introduction of a low-dose benzodiazepine to manage her evening anxiety and agitation. Initially, there appears to be a notable decrease in her anxiety levels, with the patient reporting a reduction to 4 out of 10 on the severity scale. She experiences improved sleep quality, with fewer episodes of restlessness, suggesting a positive short-term response to the medication adjustment. However, the team remains vigilant for potential side effects, given the complexities of her treatment plan.
During this period, the patient's vital signs remain stable, with a blood pressure of 116/78 mmHg and a heart rate of 70 beats per minute. Her sodium levels are consistently monitored and remain within the normal range, currently at 137 mEq/L. Despite these encouraging signs, the patient begins to express concerns about feeling overly sedated during the day, impacting her ability to engage fully in her DBT sessions. This presents a new challenge for the team, as they seek to balance the management of her anxiety symptoms with her functional capacity and participation in therapy.
In response to the patient's feedback, the clinical team considers adjusting the timing or dosage of the benzodiazepine to minimize daytime sedation while continuing to support her mental health needs. They also explore non-pharmacological strategies, such as mindfulness exercises and relaxation techniques, to complement her treatment plan. The team recognizes the importance of tailoring interventions to maintain her progress and prevent any regression in her condition, ensuring a holistic and patient-centered approach to her care. As they navigate these complexities, they remain committed to evaluating her evolving needs and making informed decisions to support her overall well-being.